digiMedical Solutions, Inc.(TM) Launches New Prescription Re-Authorization Services Website

COLLEYVILLE, TX--(Marketwire - April 22, 2009) - digiMedical Solutions, Inc.™ (PINKSHEETS: DGMS) today announced the Company has launched a new website that will be the focal point of the services offered by digiMedical's product digiReAuth™.

digiReAuth™ provides doctors' offices and clinics with a digital prescription re-authorization call center and refill system. The call center intercepts and manages calls to doctors' offices and clinics from patients and pharmacists seeking a re-authorization of a prescription. The digiReAuth™ system and services is a quick and cost-effective process that relieves the doctor's office or clinic of answering potentially thousands of phone calls per month related to prescriptions handling.

Doctors' offices and clinics currently spend, on average, $5-$7 per re-authorization call that they handle. digiReAuth™ provides a significant cost savings for each of the doctors' offices and clinics that have implemented these services. digiReAuth™ can be implemented quickly with little or no impact on the clinic or office. For more information on digiReAuth™ system and services, please visit www.digiReAuth.com.

To be added to digiMedical's corporate e-mail list to receive company updates, please send an e-mail to ir@digimedical.com.

About digiMedical Solutions, Inc.™ (www.digiMedical.com)

digiMedical Solutions, Inc.™ is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, direct marketing of the company's digital call center services for refills and reauthorization and partnering with independent pharmacy chains to focus sales with the technology suite.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission.

Contact Information: Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 ir@digimedical.com www.digimedical.com